Management

 

collidion_management_team_photo.png

Hoji Alimi

FOUNDER, CHAIRMAN AND CEO

  • 20 years of experience in the global healthcare industry
  • Chairman, CEO Ruthigen, Inc.
  • IPO experience, including raising $170M in capital
  • FDA and CE approvals of multiple drugs and devices 
 

Bill Watson

CO-FOUNDER, VP OF  BUSINESS DEVELOPMENT AND SALES

  • Vice President, Sales and Business Development
  • Investment Banker completed over $400M in transactions
  • Director of National Investment Bankers Association 

Sameer Harish

DIRECTOR OF FINANCE

  • Served as Chief Financial Officer of Ruthigen, Inc.
  • Buy-side and Sell-side equity research analyst covering medical devices and diagnostics sectors with Symmetry Capital, Needham & Co., and ThinkEquity
  • Held research positions at Guidant (now Abbott Laboratories) and Synteni (acquired by Incyte Corporation)